A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer
Clinical trial NCT04523272 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04523272
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2025-06-01
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.